CANCERSUX Trademark

Trademark Overview


On Wednesday, July 9, 2025, a trademark application was filed for CANCERSUX with the United States Patent and Trademark Office. The USPTO has given the CANCERSUX trademark a serial number of 99275227. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, January 23, 2026. This trademark is owned by Amoura.Life LLC. The CANCERSUX trademark is filed in the Staple Food Products category with the following description:

Non-medicated lozenges
cancersux

General Information


Serial Number99275227
Word MarkCANCERSUX
Filing DateWednesday, July 9, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateFriday, January 23, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkCANCER SUCKS
Goods and ServicesNon-medicated lozenges
Description of MarkThe mark consists of a graphic depiction of a minimalist, geometric owl above the literal element "CancerSux".

Classification Information


International Class030 - Coffee, tea, cocoa, sugar, rice, tapioca, sago, artificial coffee; flour and preparations made from cereals, bread, pastry and confectionery, ices; honey, treacle; yeast, baking powder; salt, mustard; vinegar, sauces (condiments); spices; ice.
US Class Codes046
Class Status Code6 - Active
Class Status DateWednesday, July 9, 2025
Primary Code030
First Use Anywhere DateTuesday, April 1, 2025
First Use In Commerce DateTuesday, April 1, 2025

Trademark Owner History


Party NameAmoura.Life LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSheridan, WY 82801

Trademark Events


Event DateEvent Description
Wednesday, July 9, 2025NEW APPLICATION ENTERED
Wednesday, July 9, 2025APPLICATION FILING RECEIPT MAILED
Friday, November 14, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 14, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, November 28, 2025ASSIGNED TO EXAMINER
Tuesday, December 2, 2025NON-FINAL ACTION WRITTEN
Tuesday, December 2, 2025NON-FINAL ACTION E-MAILED
Tuesday, December 2, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 23, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 23, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 23, 2026TEAS/EMAIL CORRESPONDENCE ENTERED

Related Keywords


cancersux lozenges medicated